RefleXion Medical

RefleXion Medical, founded in Hayward, United States, is dedicated to revolutionizing cancer treatment through its innovative biology-guided radiotherapy (BgRT). The company's core mission is to detect and respond to signals emitted by cancer cells, using these signals to guide immediate and precise treatment. RefleXion's flagship product, SCINTIX® therapy, targets tumors in the lung or bone, offering a groundbreaking approach to radiotherapy that aims to improve patient outcomes and expand treatment options.

Notable figures affiliated with RefleXion Medical include leaders in oncology and medical technology, though specific names are not provided. The company has garnered significant attention and investment from the medical community for its pioneering technology. Key achievements include the development and clinical implementation of SCINTIX® therapy, which has the potential to transform radiotherapy practices. Overall, RefleXion Medical's impact lies in its innovative approach to cancer treatment, promising more effective and immediate responses to cancerous tumors.